DRAGEN’s Germline, Somatic and RNA Gene Fusion Detection Pipelines are now commercially available on Seven Bridges, enabling new and existing Seven Bridges’ customers to leverage DRAGEN’s ultra rapid speeds and accuracy.
The DRAGEN suite of pipelines deliver industry leading speeds and scalability. In contrast to 20 to 30 hours using traditional technologies, such as BWA-GATK, DRAGEN is able to analyze a whole human genome at 30x coverage in approximately 20 minutes. The DRAGEN suite of applications on Seven Bridges is enabled through Amazon Web Services’ (AWS) EC2 F1 Instances, allowing DRAGEN in the cloud to achieve the same industry leading speeds as its onsite solution without the upfront investment costs.
For technical support or additional information about DRAGEN on Seven Bridges, click here.